CYTOKINETICS INC
CYTK· Nasdaq· Pharmaceutical Preparations
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -607.5%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +9.5%
We record prices for the companies we cover; CYTK is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 120,103
- Revenue
- $88.0M
- Free cash flow
- -$534.8M
- Owner earnings
- -$647.1M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- -695.4%
- Net
- -891.6%
- Free cash flow
- -607.5%
- Owner earnings
- -735.0%
- Stock pay
- 127.5%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- –
- ROE, 5 yr avg
- –
Growth (CAGR)
- Revenue, 3 yr
- -2.4%
- Revenue, 5 yr
- 9.5%
- Revenue, 9 yr
- -2.1%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Diluted EPS, 9 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
- Free cash flow, 9 yr
- –
Financial health · FY2025
- Cash and investments
- $882.2M
- Total debt
- $287.6M
- Net cash
- $594.7M
- Debt/Equity
- –
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- 13.2%
Financials: ten years from the 10-Ks
Revenue
$88.0M
-2.1% a year over 9 years
FY2016FY2025
Margins
Operating-695.4%Net-891.6%
FY2025
FY2016FY2025
Free cash flow and owner earnings
Free cash flow-$534.8MOwner earnings-$647.1M
FY2025
FY2016FY2025
Diluted shares
120,103
-99.7% over 9 years, net buybacks
FY2016FY2025
Net cash
$594.7M
$594.7M more cash than debt
FY2016FY2025
Every figure, year by year
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| The business | ||||||||||
| Revenue | $106.4M | $13.4M | $31.5M | $26.9M | $55.8M | $70.4M | $94.6M | $7.5M | $18.5M | $88.0M |
| Revenue growth | 271.3% | -87.4% | 135.6% | -14.7% | 107.8% | 26.2% | 34.3% | -92.0% | 145.3% | 376.6% |
| Gross margin | – | – | – | – | – | – | – | – | – | – |
| Operating margin | 17.6% | -848.3% | -282.3% | -368.0% | -168.3% | -264.5% | -342.8% | -6589.7% | -2902.7% | -695.4% |
| Net income | $16.5M | -$127.8M | -$106.3M | -$121.7M | -$127.3M | -$215.3M | -$389.0M | -$526.2M | -$589.5M | -$785.0M |
| Net margin | 15.5% | -955.9% | -337.4% | -452.9% | -228.0% | -305.7% | -411.2% | -6988.6% | -3191.1% | -891.6% |
| Diluted EPS | $0.39 | $-2.59 | – | – | $-1.97 | $-2.80 | $-4.33 | $-5.45 | $-5.26 | $-6.54 |
| Return on invested capital? | – | – | – | – | – | – | – | – | – | – |
| Cash | ||||||||||
| Operating cash flow | $37.0M | -$101.8M | -$101.2M | -$90.9M | $8.9M | -$142.5M | -$299.5M | -$414.3M | -$395.9M | -$510.0M |
| Capital expenditure | $1.6M | $2.9M | $889.0K | $2.6M | $11.1M | $48.9M | $11.3M | $1.4M | $3.9M | $24.8M |
| Free cash flow | $35.4M | -$104.6M | -$102.1M | -$93.5M | -$2.1M | -$191.4M | -$310.9M | -$415.7M | -$399.8M | -$534.8M |
| Stock-based compensation | $7.1M | $9.0M | $9.8M | $10.8M | $17.6M | $26.8M | $47.9M | $72.1M | $97.8M | $112.3M |
| Owner earnings? | $28.2M | -$113.7M | -$111.9M | -$104.3M | -$19.7M | -$218.2M | -$358.7M | -$487.8M | -$497.6M | -$647.1M |
| Free cash flow per share | $0.83 | $-2.12 | – | – | $-32.69 | $-2,489.32 | $-3,460.63 | $-4,307.21 | $-3,570.28 | $-4,452.98 |
| Capital allocation | ||||||||||
| Dividends paid | – | – | – | – | – | – | – | – | – | – |
| Share repurchases | – | – | – | – | – | – | – | – | – | – |
| Diluted shares | 42.6M | 49.4M | – | – | 64,524 | 76,886 | 89,825 | 96,524 | 111,979 | 120,103 |
| Share count change? | 9.7% | 16.1% | – | – | – | 19.2% | 16.8% | 7.5% | 16.0% | 7.3% |
| Balance sheet | ||||||||||
| Cash and equivalents | $66.9M | $125.2M | $42.3M | $36.4M | $83.0M | $112.7M | $65.6M | $113.0M | $94.9M | $122.5M |
| Short-term investments | $89.4M | $143.7M | $156.5M | $188.7M | $381.1M | $359.0M | $717.0M | $501.8M | $981.2M | $759.7M |
| Total debt | $29.9M | $31.8M | $42.4M | $45.1M | $46.2M | $47.4M | $64.8M | $68.5M | $104.7M | $287.6M |
| Net debt | -$126.4M | -$237.1M | -$156.3M | -$180.1M | -$417.9M | -$424.3M | -$717.8M | -$546.4M | -$971.3M | -$594.7M |
| Shareholders' equity | $94.4M | $109.8M | $25.9M | -$10.9M | $113.4M | $243.9M | -$107.9M | -$386.3M | -$135.4M | -$659.6M |
Latest filings
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-08-06 | 8-K | Earnings release |
| 2026-05-05 | 10-Q | Quarterly report |
| 2026-05-05 | 8-K | Earnings release |
| 2026-04-17 | DEF 14A | Proxy statement |
| 2026-02-26 | 10-K | Annual report |
| 2026-02-24 | 8-K | Earnings release |
| 2025-11-05 | 10-Q | Quarterly report |
| 2025-11-05 | 8-K | Earnings release |
| 2025-08-07 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
